Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Furio Colivicchi

Showing results (211-220 of 486) with videos related to

Pageof 49
Sort By:
Plos One|July 13, 2018
Characteristics, treatment and quality of life of stable coronary artery disease patients with or without angina: Insights from the START studyLeonardo De Luca, Pier Luigi Temporelli, Donata Lucci, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|January 17, 2019
Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START studyLeonardo De Luca, Pier Luigi Temporelli, Carmine Riccio, et al.
International Journal of Cardiology|January 4, 2024
Working in interventional cardiology laboratories: The perceived impact of radiation exposure as a health and gender hazard. A NEXT generation ANMCO initiativeChiara Bernelli, Stefania Angela Di Fusco, Andrea Matteucci, et al.
Giornale Italiano Di Cardiologia (2006)|March 27, 2023
[The early use of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes and high cardiovascular risk]Federico Nardi, Stefania Angela Di Fusco, Antonella Spinelli, et al.
European Journal of Heart Failure|March 18, 2022
Impact of the COVID-19 pandemic on prescription of sacubitril/valsartan in ItalyGiuseppe M C Rosano, Simone Celant, Pier Paolo Olimpieri, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|December 14, 2024
Two still unanswered questions about uric acid and cardiovascular prevention: Is a specific uric acid cut-off needed? Is hypouricemic treatment able to reduce cardiovascular risk?Alessandro Maloberti, Valentina Colombo, Francesca Daus, et al.
Giornale Italiano Di Cardiologia (2006)|August 29, 2023
[Electrical storm management in the cardiac care unit]Veronica Dusi, Gaetano Maria De Ferrari, Pasquale Vergara, et al.
Clinical Cardiology|July 25, 2018
Prevalence and pharmacologic management of familial hypercholesterolemia in an unselected contemporary cohort of patients with stable coronary artery diseaseLeonardo De Luca, Marcello Arca, Pier L Temporelli, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|September 23, 2025
Age- and Sex-related Differences in Heart Failure Characteristics and Treatment Patterns Across the Ejection Fraction Spectrum: First Data from the BRING-UP-3 Heart Failure StudyChristian Basile, Fabrizio Oliva, Francesco Orso, et al.
Giornale Italiano Di Cardiologia (2006)|February 3, 2025
[Occupational radioexposure in women in cardiology]Chiara Bernelli, Stefania Angela Di Fusco, Nunzia Borrelli, et al.
Pageof 49

Showing results (211-220 of 486) with videos related to

Sort By:
Pageof 49
Plos One|July 13, 2018
Characteristics, treatment and quality of life of stable coronary artery disease patients with or without angina: Insights from the START studyLeonardo De Luca, Pier Luigi Temporelli, Donata Lucci, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|January 17, 2019
Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START studyLeonardo De Luca, Pier Luigi Temporelli, Carmine Riccio, et al.
International Journal of Cardiology|January 4, 2024
Working in interventional cardiology laboratories: The perceived impact of radiation exposure as a health and gender hazard. A NEXT generation ANMCO initiativeChiara Bernelli, Stefania Angela Di Fusco, Andrea Matteucci, et al.
Giornale Italiano Di Cardiologia (2006)|March 27, 2023
[The early use of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes and high cardiovascular risk]Federico Nardi, Stefania Angela Di Fusco, Antonella Spinelli, et al.
European Journal of Heart Failure|March 18, 2022
Impact of the COVID-19 pandemic on prescription of sacubitril/valsartan in ItalyGiuseppe M C Rosano, Simone Celant, Pier Paolo Olimpieri, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|December 14, 2024
Two still unanswered questions about uric acid and cardiovascular prevention: Is a specific uric acid cut-off needed? Is hypouricemic treatment able to reduce cardiovascular risk?Alessandro Maloberti, Valentina Colombo, Francesca Daus, et al.
Giornale Italiano Di Cardiologia (2006)|August 29, 2023
[Electrical storm management in the cardiac care unit]Veronica Dusi, Gaetano Maria De Ferrari, Pasquale Vergara, et al.
Clinical Cardiology|July 25, 2018
Prevalence and pharmacologic management of familial hypercholesterolemia in an unselected contemporary cohort of patients with stable coronary artery diseaseLeonardo De Luca, Marcello Arca, Pier L Temporelli, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|September 23, 2025
Age- and Sex-related Differences in Heart Failure Characteristics and Treatment Patterns Across the Ejection Fraction Spectrum: First Data from the BRING-UP-3 Heart Failure StudyChristian Basile, Fabrizio Oliva, Francesco Orso, et al.
Giornale Italiano Di Cardiologia (2006)|February 3, 2025
[Occupational radioexposure in women in cardiology]Chiara Bernelli, Stefania Angela Di Fusco, Nunzia Borrelli, et al.
Pageof 49